CRDO
From Preclinical to Commercialization: A CRDO Approach to Accelerating Biologic Development
Matthias Lucke, Ph.D.; Ivonne Stelzl, Ph.D.
Coriolis Pharma
PAO-08-25-CL-02Aug 04, 2025
Drug Development
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
REGENXBIO
PR-01-25-NI-12Jan 14, 2025
Clinical Trials
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Therapies Clinical Trials and Commercialization
Chime Biologics
PR-01-25-NI-01Jan 03, 2025
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10Sep 17, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02Mar 08, 2024
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
Dongyoung Park
Samsung Biologics
PAO-03-24-CL-01Mar 04, 2024
New Facility
Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin
Synbiotic Health
PR-M11-22-02Nov 02, 2022
Commercialization
Evolve Biologics Provides Business Update on Progress Toward Commercialization of Innovative Plasmacap EBA® Technology
Evolve Biologics
PR-M11-20-047Mar 10, 2021
Partnership
Facilitating the Commercialization of Disruptive Industrial Life Science Technologies
Gustavo Mahler, Ph.D.; Daniella Kranjac
Dynamk Capital
PAP-Q1-20-CL-031Mar 19, 2020
Genfit Gets New CEO as it Moves to Approval and Commercialization Stage
Pharma's Almanac
PA2119Sep 11, 2019
Series B Financing
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
Purigen Biosystems
PR-M06-19-NI-022Jun 17, 2019
Commercialization
Supporting Commercialization with Specialized Technologies
Joseph Szczesiul
UPM Pharmaceuticals
PAP-Q2-2019-CL-034May 24, 2019
Orphan Drug Development
Navigating the Road to Successful Orphan Drug Commercialization and Launch
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-2019-NI-003May 24, 2019
AAV and LV Vectors
Supporting AAV and Lentiviral Vector Development and Commercialization
James Brown, Ph.D.
Aldevron
PAP-Q2-2019-CL-005May 24, 2019
Commercialization
Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazol
Pulmatrix
PR-M04-19-NI-023Apr 05, 2019
Investment
Successful Funding Round Could Lead to Commercialization of Bio-integrative Bone Pin
Pharma's Almanac
PAO-M03-19-NI-023Mar 12, 2019
HPAPI
Investing in the Future of Potent Compounds
Frederic Desdouits
Seqens
PAP-Q1-2019-CL-028Mar 12, 2019
Pre-Natal
NX Prenatal and Milu Labs Announce Strategic Collaboration to Commercialize Exosome-Based Preterm Birth Risk Test in Asia
NX Prenatal
PR-M01-19-NI-059Jan 21, 2019
Regulatory
Reducing Time to Market with Targeted Regulatory Affairs Support
Maryse Phan
Servier
PAO-06-18-CL-003Jun 20, 2018
Drug Development
PharmaFluidics Raises 7.3 Million Euro to Expand Commercialization of Novel Micro-Chip Device for Biomarker, Diagnostics and Drug Development Applications
PharmaFluidics
PR-M01-18-NI-044Jan 16, 2018